Alps Group Inc
ALPSHealthcare|Biotechnology|MY
$0.33
+0.02 (+4.90%)
DCF Value
$0.11
Cash / Share
$0.17
Financials
Financial Snapshot
Market Cap
$54.9M
Enterprise Value
$54.8M
Revenue (TTM)
$0.00
Net Income (TTM)
-$2.7M
Cash & Investments
$607.5K
Net Cash
$48.2K
Free Cash Flow (TTM)
-$962.4K
Operating CF (TTM)
-$962.4K
Debt/Equity
-0.19
Cash Runway & Burn Rate
Cash on Hand
$607.5K
Quarterly Burn
$240.6K
Monthly Burn
$80.2K
Est. Runway
~2.5 quarters
| Metric | Trend | 2021 | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Cash & Investments | $812.2K | $81.8K | $460.5K | $318.9K | $607.5K | $607.5K | |
| Operating Cash Flow | -$324.9K | -$113.6K | -$1.4M | -$1.6M | -$2.6M | -$962.4K | |
| Free Cash Flow | -$324.9K | -$388.0K | -$1.6M | -$1.7M | -$2.6M | -$962.4K | |
| Capital Expenditure | $0.00 | -$274.5K | -$221.3K | -$83.8K | -$56.4K | $4.00 | |
| Financing Cash Flow | $117.9M | $212.9K | $3.3M | $1.9M | -$24.4M | -$27.5M |
Income Statement
| Metric | Trend | 2021 | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $3.6M | $2.4M | $3.4M | $4.9M | $0.00 | |
| Cost of Revenue | $0.00 | $1.6M | $1.8M | $2.1M | $3.3M | $0.00 | |
| Gross Profit | $0.00 | $2.0M | $598.9K | $1.3M | $1.6M | $0.00 | |
| R&D | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| SG&A | $135.6K | $26.1M | $2.1M | $2.7M | $3.7M | $1.2M | |
| Operating Income | -$135.6K | -$535.5K | -$2.4M | -$2.5M | -$3.4M | -$1.8M | |
| Interest Expense | $0.00 | $46.6K | $42.8K | $48.3K | $50.5K | $1.2M | |
| Pretax Income | -$119.6K | -$582.1K | -$2.4M | -$2.5M | -$2.1M | -$2.7M | |
| Net Income | -$119.6K | -$729.2K | -$2.3M | -$2.5M | -$2.0M | -$2.7M | |
| EPS (Diluted) | -0.01 | -0.00 | -0.01 | -0.02 | -0.02 | -0.73 | |
| EBITDA | -$135.6K | $363.2K | -$1.5M | -$1.4M | -$901.4K | -$1.5M | |
| Shares Out. (M) | 14.94 | 53.59 | 160.00 | 160.00 | 162.40 | 3.52 |
Balance Sheet
| Metric | Trend | 2021 | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $812.2K | $81.8K | $460.5K | $318.9K | $607.5K | $607.5K | |
| Short-Term Investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Total Current Assets | $1.0M | $530.5K | $1.3M | $1.5M | $2.0M | $2.0M | |
| Total Assets | $118.0M | $119.2M | $6.7M | $7.1M | $7.0M | $7.0M | |
| Total Current Liabilities | $230.8K | $813.3K | $5.1M | $7.5M | $5.5M | $5.5M | |
| Long-Term Debt | $0.00 | $0.00 | $0.00 | $738.2K | $4.6M | $0.00 | |
| Total Liabilities | $4.4M | $4.8M | $5.2M | $8.2M | $10.2M | $10.2M | |
| Stockholders' Equity | $113.6M | $113.8M | $1.6M | -$888.6K | -$2.9M | -$2.9M | |
| Retained Earnings | -$3.1M | -$4.1M | -$8.7M | -$11.2M | -$13.2M | -$13.2M |
Cash Flow Statement
| Metric | Trend | 2021 | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$324.9K | -$113.6K | -$1.4M | -$1.6M | -$2.6M | -$962.4K | |
| Capital Expenditure | $0.00 | -$274.5K | -$221.3K | -$83.8K | -$56.4K | $4.00 | |
| Free Cash Flow | -$324.9K | -$388.0K | -$1.6M | -$1.7M | -$2.6M | -$962.4K | |
| Investing Cash Flow | -$116.7M | -$288.3K | -$1.7M | -$100.1K | $26.6M | $28.8M | |
| Financing Cash Flow | $117.9M | $212.9K | $3.3M | $1.9M | -$24.4M | -$27.5M | |
| Issuance of Stock | $117.9M | $0.00 | $2.3M | $0.00 | $3.1M | $0.00 | |
| Repurchase of Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$29.5M | |
| Net Debt Issuance | $0.00 | -$345.2K | $1.5M | $2.4M | $165.1K | $1.5M | |
| Stock Based Comp. | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Net Change in Cash | $812.2K | -$213.1K | $197.6K | $157.7K | $174.4K | $292.5K |
Dilution Tracker
Shares outstanding grew 986.7% over 5 years — significant dilution
Shares Outstanding
166M
5-Year Share Growth
+986.7%
Stock Issuance (TTM)
$0.00
| Metric | Trend | 2021 | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Shares Out. (M) | 14.94 | 53.59 | 160.00 | 160.00 | 162.40 | 3.52 | |
| Change vs Prior % | — | 258.6% | 198.6% | 0.0% | 1.5% | -97.8% | |
| Stock Issuance | $117.9M | $0.00 | $2.3M | $0.00 | $3.1M | $0.00 | |
| Stock Repurchase | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$29.5M | |
| Stock Based Comp. | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Margins & Profitability
| Metric | Trend | 2021 | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Gross Margin % | — | 55.0% | 24.9% | 38.6% | 32.1% | — | |
| Operating Margin % | — | -14.9% | -100.2% | -74.2% | -69.6% | — | |
| Net Margin % | — | -20.3% | -95.9% | -74.6% | -41.4% | — | |
| EBITDA Margin % | — | 10.1% | -60.4% | -40.1% | -18.6% | — | |
| FCF Margin % | — | -10.8% | -66.1% | -50.2% | -54.2% | — | |
| ROE % | -0.1% | -0.6% | -147.0% | 282.9% | 68.7% | 20.7% | |
| ROA % | -0.1% | -0.6% | -34.4% | -35.2% | -28.8% | -24.7% | |
| ROIC % | -0.1% | -0.5% | -122.6% | -41.3% | -180.2% | -48.1% | |
| R&D / Revenue % | — | 0.0% | 0.0% | 0.0% | 0.0% | — |
Growth (Year over Year)
Fiscal years. Rising share count growth means dilution.
| Metric | Trend | 2021 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Revenue | 0.0% | 0.0% | -33.1% | 40.3% | 44.1% | |
| Gross Profit | 0.0% | 0.0% | -69.7% | 117.3% | 19.8% | |
| Operating Income | 0.0% | 0.0% | -349.9% | -3.8% | -35.2% | |
| Net Income | 0.0% | 0.0% | -216.0% | -9.1% | 20.1% | |
| EPS (Diluted) | 0.0% | 0.0% | -127.3% | -100.0% | 0.0% | |
| Operating Cash Flow | 0.0% | 0.0% | -1103.4% | -17.7% | -60.1% | |
| Free Cash Flow | 0.0% | 0.0% | -309.3% | -6.6% | -55.5% | |
| R&D Expense | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| SG&A Expense | 0.0% | 0.0% | -92.0% | 27.9% | 38.5% | |
| Total Assets | 0.0% | 0.0% | -94.4% | 6.5% | -2.3% | |
| Book Value / Share | 0.0% | 0.0% | -99.7% | -176.9% | -185.2% | |
| Debt | 0.0% | 0.0% | 0.0% | 1266.1% | -91.9% | |
| Diluted Shares | 0.0% | 0.0% | 198.6% | 0.0% | 1.5% |
Valuation
P/E (TTM)At Loss
P/S0.00
10Y Low / Med / High33.44 / 570.03 / 799.48
P/B-0.40
10Y Low / Med / High1.58 / 3.64 / 1226.15
EV/EBITDAAt Loss
EV/Revenue0.00
10Y Low / Med / High33.43 / 571.99 / 799.50
P/FCFAt Loss
Intrinsic Value Models (per share)
DCF Value
$0.11
Cash / Share
$0.17
| Metric | Trend | 2021 | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|---|---|
| P/E Ratio | -1501.25 | -600.50 | -1201.00 | -600.50 | -50.00 | -0.69 | |
| P/S Ratio | 0.00 | 115.11 | 799.48 | 570.03 | 33.44 | 0.00 | |
| P/B Ratio | 1.58 | 3.64 | 1226.15 | -2162.60 | -55.53 | -0.40 | |
| EV/EBITDA | -1317.20 | 1139.14 | -1323.18 | -1425.81 | -180.12 | -61.85 | |
| EV/Revenue | 0.00 | 115.08 | 799.50 | 571.99 | 33.43 | 0.00 |
Analyst Estimates & Quality
Altman Z-Score
-0.74
Distress
Piotroski F-Score
3
Weak